• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Experimental scorpio anti-venom 'protects kids from poisonous sting'

By Super Admin
|

Washington, May 14 (ANI): An experimental anti-venom has been found effective in protecting children against scorpion sting, say researchers.

Lead researcher Dr Leslie Boyer, director of the VIPER (Venom Immunochemistry, Pharmacology and Emergency Response) Institute at The University of Arizona College of Medicine examined 15 children admitted to a pediatric intensive care unit following a bark scorpion sting.

They were experiencing abnormal eye movements, uncontrolled thrashing of limbs and respiratory distress - all symptoms of nerve poisoning.

In the study, eight of the children, most of whom were under 6 years, received a scorpion antivenom and seven other participants received a placebo.

The researchers found that symptoms of nerve poisoning were resolved in all of the children treated with the antivenom in less than four hours, and usually within two hours.

The children who received the placebo continued to experience nerve poisoning for four hours or more and required large doses of sedative medication and extended hospitalization.

"This study told us that the dangerous effects of bark scorpion venom can be reversed quickly with the right antivenom," said Dr. Boyer.

"One hundred percent of the children who received it got better very quickly, meaning that using this antivenom in the emergency room will make intensive care treatment unnecessary for most patients.

"This is particularly important in small Arizona towns without pediatric intensive care units. By avoiding helicopter trips and intensive care stays, we can save lives and keep treatment costs down at the same time," Boyer added. (ANI)

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more